Supha Pharmachem Ltd
Supha Pharmachem Ltd (SUPHA) last reported results for the quarter ended Sep 2025, with sales of ₹111 crore and net profit of ₹8.62 crore. The stock last traded at ₹0.26, a market capitalisation of ₹22.9 crore, on a P/E of 10.8. Over the past 52 weeks the stock has ranged between ₹0.25 and ₹1.8. Figures are as of 6 Oct 2026 and are not real time.
Supha Pharmachem Ltd share price and key metrics
- Current price
- ₹0.26
- Market cap
- ₹22.9 cr
- Stock P/E
- 10.8
- Book value
- ₹1.19
- ROE
- 4.85%
- ROCE
- %
- Dividend yield
- 0.00%
- 52w high / low
- 1.80/0.25
Metrics as of 6 Oct 2026. Not real time.
Track Supha Pharmachem Ltd
Cruxal reads every Supha Pharmachem Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Supha Pharmachem Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- -40%
- 3 Years
- -86%
- 1 Year
- -84%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- 5%
Supha Pharmachem Ltd quarterly results
| ₹ crore | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|
| Sales | 264 | 113 | 111 |
| Expenses | 265 | 112 | 104 |
| Operating profit | -0.46 | 1.87 | 7.38 |
| OPM % | -0.17% | 1.65% | 6.65% |
| Other income | 0.66 | 3.48 | 3.25 |
| Interest | 1.59 | -0.36 | 0.19 |
| Depreciation | 0.01 | 0 | 0 |
| Profit before tax | -1.4 | 5.71 | 10.44 |
| Tax % | 45.71% | 18.56% | 17.34% |
| Net profit | -2.05 | 4.65 | 8.62 |
| EPS (₹) | -0.02 | 0.05 | 0.10 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Supha Pharmachem Ltd annual results
| ₹ crore | Mar 2025 |
|---|---|
| Sales | 405 |
| Operating profit | 1 |
| OPM % | 0.3% |
| Net profit | 2 |
| EPS (₹) | 0.02 |
TTM is the trailing twelve months to the most recent quarter.
Supha Pharmachem Ltd balance sheet
| ₹ crore | Mar 2025 | Sep 2025 |
|---|---|---|
| Equity capital | 40 | 88 |
| Reserves | 4 | 17 |
| Borrowings | 1,141 | 1,088 |
| Other liabilities | 535 | 430 |
| Total liabilities | 1,720 | 1,623 |
| Fixed assets | 0 | 6 |
| CWIP | 0 | 0 |
| Investments | 0 | 0 |
| Other assets | 1,720 | 1,617 |
| Total assets | 1,720 | 1,623 |
As reported by the company. Total assets equal total liabilities by construction.
Supha Pharmachem Ltd cash flow
| ₹ crore | Mar 2025 |
|---|---|
| Cash from operations | -1,135 |
| Cash from investing | 0 |
| Cash from financing | 1,136 |
| Net cash flow | 1 |
| Free cash flow | -1,135 |
| CFO / operating profit | -90,064% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Supha Pharmachem Ltd operating ratios
| Per year | Mar 2025 |
|---|---|
| Debtor days | 695 |
| Inventory days | 247 |
| Days payable | 459 |
| Cash conversion cycle | 483 |
| Working capital days | 38 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Supha Pharmachem Ltd shareholding pattern
Promoters held 1.13% at Dec 2025, broadly unchanged since Dec 2024. FIIs 1.70%.
| % held | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 1.11% | 1.11% | 1.11% | 1.11% | 1.11% | 1.13% | 1.13% | 1.13% |
| FIIs | 0.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.70% |
| Public | 98.85% | 98.89% | 98.89% | 98.89% | 98.89% | 98.87% | 98.87% | 97.17% |
| No. of shareholders | 15,587 | 26,464 | 67,404 | 73,637 | 1,10,422 | 1,13,543 | 1,14,119 | 1,11,269 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.